Paulness: If you knew the last 6 year history with this company and its CEO, you'd know what I was talking about. He arranges a PIPE financing first. Then he gets his PR guys to get articles written about the company, or they will announce another pre-clinical breakthrough or a new patent. Then they watch the share price rise. When they think the price has risen as far as it will go up they announce another PIPE financing, at which point the stock tanks and stays lethargic for 6-9 month afterward. This instance was classic. The stock closed Friday at $3.26. After the market closed the Barron's article became available on line. The price of the stock went up in after hours trading by about 70 cents. The increase followed thru on Monday, eventually raising the price to $4.11. Then it retreated a little. Just before the close today there were two huge sell orders for I think a total of 103,000 shares. The stock closed regular trading at $3.69. It went down another 35 cents in after hours trading. Then the company announced its PIPE deal. And, just coincidentally, the PIPE price was $3.26....the same as Friday's closing price. Manipulation? You bet. And some insiders or friends of the insiders made a nice little killing on the way up and probably on the way down after they shorted. How did someone or multiple someones know to dump 103,000 shares before the PIPE news came out? In the grand scheme of things it is not that big a deal. I'm in the stock for the long haul, and I'm still slightly profitable on it. But it burns me up to see such blatant manipulation of the capital markets, and the SEC doesn't do a damn thing about it. If I were an SEC investigator I'd have the sellers of those 103,000 shares, the management of AVII and the underwriters of the PIPE under subpoena by Tuesday morning.
AI
Market Data 
Markets 
